Search

Your search keyword '"Aucejo, Federico N."' showing total 248 results

Search Constraints

Start Over You searched for: Author "Aucejo, Federico N." Remove constraint Author: "Aucejo, Federico N."
248 results on '"Aucejo, Federico N."'

Search Results

1. Evaluating Combinations of Biological and Clinicopathologic Factors Linked to Poor Outcomes in Resected Colorectal Liver Metastasis: An External Validation Study

2. Hepatic Resection as the Primary Treatment Method for Hepatocellular Carcinoma After Orthotopic Liver Transplantation

3. ASO Visual Abstract: Evaluating Combinations of Biological and Clinicopathologic Factors Linked to Poor Outcomes in Resected Colorectal Liver Metastasis: An External Validation Study

4. ASO Visual Abstract: Hepatic Resection as the Primary Treatment Modality for Hepatocellular Carcinoma Following Orthotopic Liver Transplantation

5. ASO Author Reflections: Hepatic Resection as the Primary Treatment Modality for Hepatocellular Carcinoma After Orthotopic Liver Transplantation

9. Demystifying BRAF Mutation Status in Colorectal Liver Metastases: A Multi-institutional, Collaborative Approach to 6 Open Clinical Questions

13. Biomarker Discovery in Liver Disease Using Untargeted Metabolomics in Plasma and Saliva.

16. Correction to “Liquid Biopsy by ctDNA in Liver Transplantation for Colorectal Cancer Liver Metastasis” [J Gastrointest Surg. 2023;27(7):1498-509]

20. Serum tumor markers enhance the predictive power of the AJCC and LCSGJ staging systems in resectable intrahepatic cholangiocarcinoma

21. Preoperative Risk Score and Prediction of Long-Term Outcomes after Hepatectomy for Intrahepatic Cholangiocarcinoma

27. The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status: A Study By the International Genetic Consortium for Colorectal Liver Metastasis

30. Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases: A Multi-institutional, International Analysis of 1099 Patients

31. Left Lobe First With Purely Laparoscopic Approach.

34. Demystifying BRAF Mutation Status in Colorectal Liver Metastases: A Multi-institutional, Collaborative Approach to 6 Open Clinical Questions

36. Demystifying BRAFMutation Status in Colorectal Liver Metastases

37. Using Artificial Intelligence to Find the Optimal Margin Width in Hepatectomy for Colorectal Cancer Liver Metastases

38. Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases:Does the primary disease site matter?

39. KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations

41. The spectrum of histopathological findings after SVR to DAA for recurrent HCV infection in liver transplant recipients

43. Should We Be Utilizing More Liver Grafts From Pediatric Donation After Circulatory Death Donors? A National Analysis of the SRTR from 2002 to 2017

45. Conditional probability of graft survival in liver transplantation using donation after circulatory death grafts – a retrospective study

48. Performance of two prognostic scores that incorporate genetic information to predict long‐term outcomes following resection of colorectal cancer liver metastases: An external validation of the MD Anderson and JHH‐MSK scores

49. Neuroendocrine liver metastases: The role of liver transplantation

50. Charting the Path Forward for Risk Prediction in Liver Transplant for HCC: International Validation of HALTHCC amongst 4,089 patients

Catalog

Books, media, physical & digital resources